Source:Clinical Immunology, Volume 175
http://ift.tt/2l6X6cQ
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Publication date: Available online 14 February 2017
Source:The Journal of Steroid Biochemistry and Molecular Biology
Author(s): Kathryn E. Merriman, Michael B. Poindexter, Mercedes F. Kweh, Jose E.P. Santos, Corwin D. Nelson
Bacterial infection of the mammary gland activates an intracrine vitamin D pathway in macrophages of dairy cows. The active hormone of the vitamin D pathway, 1,25-dihydroxyvitamin D3 (1,25D), stimulates nitric oxide and β-defensin responses in bovine monocyte cultures, but the effect of 1,25D on innate immune genes in the mammary gland remained unknown. Therefore, the objective of this study was to determine the effects intramammary 1,25D treatment on expression of vitamin D associated host-defenses of the bovine mammary gland. Intramammary treatment of normal, healthy mammary glands of lactating dairy cows (n=14) with 10μg 1,25D increased inducible nitric oxide synthase (iNOS) and β-defensin 7 (DEFB7) gene expression in total milk somatic cells more than two-fold relative to placebo-treated glands within 8h after treatment. The vitamin D 24-hydroxylase gene (CYP24A1) also was increased nearly 100-fold in 1,25D-treated glands within 4h after treatment but was not affected in placebo-treated glands. Both macrophages and neutrophils isolated from milk had increased CYP24A1 expression in response to 1,25D treatment but only macrophages had increased iNOS expression. Repeated intramammary 1,25D treatment, every 12h for 48h, of infected mammary glands of cows diagnosed with subclinical mastitis resulted in increased expression of CYP24A1, DEFB4, DEFB7 and iNOS genes compared to placebo-treated glands. The 1,25D treatment resulted in elevated serum 1,25D concentrations (55 vs 33pg/mL) compared to placebo but it did not change serum calcium concentrations or bacteria counts in milk of infected mammary glands. In conclusion, 1,25D upregulates iNOS and β-defensin genes in vivo in cattle and affirms earlier reports that vitamin D supports innate immune functions of cattle.
http://ift.tt/2lJhpQL
Publication date: Available online 14 February 2017
Source:The Journal of Steroid Biochemistry and Molecular Biology
Author(s): Rati Lama, Chunfang Gan, Nethrie Idippily, Viharika Bobba, David Danielpour, Monica Montano, Bin Su
Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is identified as a novel inhibitor of estrogen stimulated breast cell growth, and it suppresses estrogen receptor-α transcriptional activity. HEXIM1 protein level has been found to be downregulated by estrogens. Recently, HEXIM1 has been found to inhibit androgen receptor transcriptional activity as well. Researchers have used Hexamethylene bis-acetamide (HMBA) for decades to stimulate HEXIM1 expression, which also inhibit estrogen stimulated breast cancer cell gene activation and androgen stimulated prostate cancer gene activation. However, the direct molecular targets of HMBA that modulate the induction of HEXIM1 expression in mammalian cells have not been identified. Based on HMBA and its more potent analog 4a1, we designed molecular probes to pull down the binding proteins of these compounds. Via proteomic approach and biological assays, we demonstrate that HMBA and 4a1 are actually heat shock protein 70 (HSP70) binders. The known HSP70 activator showed similar activity as HMBA and 4a1 to induce HEXIM1 expression, suggesting that HMBA and 4a1 might be putative HSP70 activators. Molecular target identification of HMBA and 4a1 could lead to further structural optimization of the parental compound to generate more potent derivatives to stimulate HEXIM1 expression, which could be a novel approach for hormone dependent breast cancer and prostate cancer treatment.
After lung-sparing radiotherapy for malignant pleural mesothelioma (MPM), local failure at sites of previous gross disease represents the dominant form of failure. Our aim is to investigate if selective irradiation of the gross pleural disease only can allow dose escalation.
In all, 12 consecutive stage I–IV MPM patients (6 left-sided and 6 right-sided) were retrospectively identified and included. A magnetic resonance imaging-based pleural gross tumor volume (GTV) was contoured. Two sets of planning target volumes (PTV) were generated for each patient: (1) a "selective" PTV (S-PTV), originating from a 5-mm isotropic expansion from the GTV and (2) an "elective" PTV (E-PTV), originating from a 5-mm isotropic expansion from the whole ipsilateral pleural space. Two sets of volumetric modulated arc therapy (VMAT) treatment plans were generated: a "selective" pleural irradiation plan (SPI plan) and an "elective" pleural irradiation plan (EPI plan, planned with a simultaneous integrated boost technique [SIB]).
In the SPI plans, the average median dose to the S‑PTV was 53.6 Gy (range 41–63.6 Gy). In 4 of 12 patients, it was possible to escalate the dose to the S‑PTV to >58 Gy. In the EPI plans, the average median doses to the E‑PTV and to the S‑PTV were 48.6 Gy (range 38.5–58.7) and 49 Gy (range 38.6–59.5 Gy), respectively. No significant dose escalation was achievable.
The omission of the elective irradiation of the whole ipsilateral pleural space allowed dose escalation from 49 Gy to more than 58 Gy in 4 of 12 chemonaive MPM patients. This strategy may form the basis for nonsurgical radical combined modality treatment of MPM.
In image-guided EBRT of the prostate, transperineal ultrasound (US) probes exert pressure on the perineum both during planning and treatment. Through tissue deformation and relaxation, this causes target and risk organ displacement and drift. In this study, prefraction shift and intrafraction drift of the prostate are quantified during robotic transperineal 4DUS.
The position of the prostate was recorded for different positions of the probe before treatment in 10 patients (16 series of measurements). During treatment (15 patients, 273 fractions), intrafraction motion of the prostate was tracked (total of 27 h and 24 min) with the transperineal probe in place.
Per 1 mm shift of the US probe in the cranial direction, a displacement of the prostate by 0.42 ± 0.09 mm in the cranial direction was detected. The relationship was found to be linear (R² = 0.97) and highly significant (p < 0.0001). After initial contact of the probe and the perineum (no pressure), a shift of the probe of about 5–10 mm was typically necessary to achieve good image quality, corresponding to a shift of the prostate of about 2–4 mm in the cranial direction. Tissue compression and prostate displacement were well visible. During treatment, the prostate drifted at an average rate of 0.075 mm/min in the cranial direction (p = 0.0014).
The pressure applied by a perineal US probe has a quantitatively similar impact on prostate displacement as transabdominal pressure. Shifts are predominantly in the cranial direction (typically 2–4 mm) with some component in the anterior direction (typically <1 mm). Slight probe pressure can improve image quality, but excessive probe pressure can distort the surrounding anatomy and potentially move risk organs closer to the high-dose area.
Temozolomide-(TMZ)-based chemoradiotherapy defines the current gold standard for the treatment of newly diagnosed glioblastoma. Data regarding the influence of TMZ dose density during chemoradiotherapy are currently not available. We retrospectively compared outcomes in patients receiving no TMZ, TMZ during radiotherapy on radiotherapy days only, and TMZ constantly 7 days a week.
From 2002–2012, a total of 432 patients with newly diagnosed glioblastoma received radiotherapy in our department: 118 patients had radiotherapy alone, 210 had chemoradiotherapy with TMZ (75 mg/m2) daily (7/7), and 104 with TMZ only on radiotherapy days (5/7). Radiotherapy was applied to a total dose of 60 Gy.
Median survival after radiotherapy alone was 9.1 months, compared to 12.6 months with 5/7-TMZ and to 15.7 months with 7/7-TMZ. The 1‑year survival rates were 33, 52, and 64%, respectively. Kaplan–Meier analysis showed a significant improvement of TMZ-7/7 vs. 5/7 (p = 0.01 by the log-rank test), while 5/7-TMZ was still superior to no TMZ at all (p = 0.02). Multivariate Cox regression showed a significant influence of TMZ regimen (p = 0.009) on hazard rate (+58% between groups) even in the presence of confounding factors age, sex, resection status, and radiotherapy dose concept.
Our results confirm the findings of the EORTC/NCIC trial. It seems that also a reduced TMZ scheme can at first prolong the survival of glioblastoma patients, but not as much as the daily administration.
Publication date: Available online 14 February 2017
Source:Practical Radiation Oncology
Author(s): L.A. Kachnic, D.W. Bruner, M.M. Qureshi, G.A. Russo
Purpose/ObjectivesVaginal stenosis (VS) is a recognized complication of pelvic and vaginal radiation therapy (RT).Materials/MethodsA 26-item survey assessing the signs/symptoms, risk factors, diagnosis, prevention, treatment and impact of VS on women's sexual health was distributed. Descriptive statistics were calculated. Chi-square tests examined differences in categorical responses.Results233 (10.5%) completed the entire survey. Twelve%, 21%, and 68% report treating only gynecologic (GYN) tumors, only non-GYN pelvic tumors, or both, respectively. Regarding risk factors, 78% feel that VS can be caused by pelvic RT alone, 91% by vaginal brachytherapy (VB) alone, and 98% by combined pelvic RT and VB. Approximately half of respondents felt that being post-menopausal and having a hysterectomy prior to radiation therapy were risk factors for VS, while the other half felt that these were not risk factors. All respondents agree that VS is a clinical diagnosis. Reported VS symptoms include dyspareunia, vaginal pain, dryness, and/or bleeding (100%, 90%, 85% and 72%, respectively); 65% indicate all four. The most commonly recommended treatment for VS is vaginal dilator (VD) use Radiation oncologists who treat only GYN vs. non-GYN cancers are more likely to perform a vaginal exam, to distribute written instructions regarding VD use (p=0.002), to have vaginal bleeding reported after RT (p=0.001), and to refer patients to a sexual counselor (p=0.007). Most providers (73%) expressed willingness to participate in prospective research on the diagnosis and treatment of VS.ConclusionsThis is the first large-scale survey of radiation oncologists' perceptions and practices regarding VS. There is agreement among providers regarding the signs/symptoms of VS, and strategies for the prevention/treatment using vaginal dilators. Further prospective and observational research is needed. This survey shows a willingness on the part of providers to take part in prospective research regarding the diagnosis, impact, and treatment of VS on women's sexual health.
http://ift.tt/2kopz0K
Publication date: 15 May 2017
Source:Talanta, Volume 167
Author(s): Jiwoo An, Kira L. Rahn, Jared L. Anderson
A headspace single drop microextraction (HS-SDME) method and a dispersive liquid-liquid microextraction (DLLME) method were developed using two tetrachloromanganate ([MnCl42-])-based magnetic ionic liquids (MIL) as extraction solvents for the determination of twelve aromatic compounds, including four polyaromatic hydrocarbons, by reversed phase high-performance liquid chromatography (HPLC). The analytical performance of the developed HS-SDME method was compared to the DLLME approach employing the same MILs. In the HS-SDME approach, the magnetic field generated by the magnet was exploited to suspend the MIL solvent from the tip of a rod magnet. The utilization of MILs in HS-SDME resulted in a highly stable microdroplet under elevated temperatures and long extraction times, overcoming a common challenge encountered in traditional SDME approaches of droplet instability. The low UV absorbance of the [MnCl42-]-based MILs permitted direct analysis of the analyte enriched extraction solvent by HPLC. In HS-SDME, the effects of ionic strength of the sample solution, temperature of the extraction system, extraction time, stir rate, and headspace volume on extraction efficiencies were examined. Coefficients of determination (R2) ranged from 0.994 to 0.999 and limits of detection (LODs) varied from 0.04 to 1.0μgL−1 with relative recoveries from lake water ranging from 70.2% to 109.6%. For the DLLME method, parameters including disperser solvent type and volume, ionic strength of the sample solution, mass of extraction solvent, and extraction time were studied and optimized. Coefficients of determination for the DLLME method varied from 0.997 to 0.999 with LODs ranging from 0.05 to 1.0μgL−1. Relative recoveries from lake water samples ranged from 68.7% to 104.5%. Overall, the DLLME approach permitted faster extraction times and higher enrichment factors for analytes with low vapor pressure whereas the HS-SDME approach exhibited better extraction efficiencies for analytes with relatively higher vapor pressure.
Publication date: 15 May 2017
Source:Talanta, Volume 167
Author(s): Yongliang Chen, Xiuling Li, Ming Yang, Libin Yang, Xiaoxia Han, Xin Jiang, Bing Zhao
The antibiotic residue in animal source foods (milk, meat, etc.) is threatening people's health due to its abusing in livestock breeding more and more seriously. In this study, a simple and sensitive SERS method coupled with a two-step pretreatment process of sample was proposed for the residue detection of penicillin G (PENG) in real milk sample. It can be found that the two-step pretreatment process of sample is an essential procedure for the successful detection of PENG residue in milk, which can effectively avoid interference from other components in the sample and achieve the trace-level detection of PENG residue by SERS. Under the optimal test conditions, the limit of detection of PENG residue is 2.54×10−9mol/L (equal to 0.85μg/kg), which is lower than the standard of the European Union (4μg/kg). And, there is a good linear relationship (R2=0.9902) in the concentration range of 1.0×10−8~1.0×10−3mol/L. By this method, the recovery of PENG residue ranges from 76% to 97% with relative standard deviation between 4.8% and 2.1%. The proposed SERS method can be effectively applied for determination of PENG residue in milk.
Publication date: 15 May 2017
Source:Talanta, Volume 167
Author(s): F.E. Ortega-Ojeda, M. Torre-Roldán, C. García-Ruiz
This work used chemical imaging in the short-wave infrared region for analysing gunshot residues (GSR) patterns in cotton fabric targets shot with conventional and non-toxic ammunition. It presents a non-destructive, non-toxic, highly visual and hiperspectral-based approach. The method was based on classical least squares regression, and was tested with the ammunition propellants and their standard components' spectra. The propellants' spectra were satisfactorily used (R2 >0.966, and CorrCoef >0.982) for identifying the GSR irrespective of the type of ammunition used for the shooting. In a more versatile approach, nitrocellulose, the main component in the ammunition propellants, resulted an excellent standard for identifying GSR patterns (R2>0.842, and CorrCoef >0.908). In this case, the propellants' stabilizers (diphenilamine and centralite), and its nitrated derivatives as well as dinitrotoluene, showed also high spectral activity. Therefore, they could be recommended as complementary standards for confirming the GSR identification. These findings establish the proof of concept for a science-based evidence useful to support expert reports and final court rulings. This approach for obtaining GSR patterns can be an excellent alternative to the current and traditional chemical methods, which are based in presumptive and invasive colour tests.
Publication date: 15 May 2017
Source:Talanta, Volume 167
Author(s): Xiu Li, Guang Chen, Jianjun Liu, Yuxia Liu, Xianen Zhao, Ziping Cao, Lian Xia, Guoliang Li, Zhiwei Sun, Shijuan Zhang, Hua Wang, Jinmao You
A rapid, accurate and sensitive method, using the stable isotope labeling (SIL), microwave-assisted dispersive liquid-liquid micro extraction (MADLLME) and the ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), was developed and validated for the determination of hydroxyl UV Filters in environmental water samples. A pair of new isotopic tags D0-/D3-1-methylindole-3-acetic acid (D0-/D3-MIAA) is synthesized, with which a simple yet efficient pretreatment MADLLME-SIL is developed. Under the optimized conditions (80℃, 240W, 180s), the sample pretreatment including analyte extraction, pre-concentration and isotope labeling can be finished conveniently in only 9min. D0-/D3-MIAA labeling improves the chromatographic retention by strengthening the hydrophobicity and enhances the MS response for 3–4 orders of magnitude. Excellent linearity is established by the H/D ratios of 1/10–10/1 with the correlation coefficients >0.9990. The quite low detection limits (0.54–1.79ng/L) are achieved, ensuring the trace detection. This method is successfully applied to a series of environmental water samples. The recoveries (93.2%~103.5%) are significantly improved and the analysis time is largely reduced (<15min). The excellent sensitivity, accuracy, recovery, and efficiency demonstrate this MADLLME-SIL-LC-MS/MS method a superior alternative for the analysis of UV filters in water samples.
Publication date: Available online 14 February 2017
Source:Free Radical Biology and Medicine
Author(s): Mercedes Muñoz, Maria Elvira López-Oliva, Estéfano Pinilla, María Pilar Martínez, Ana Sánchez, Claudia Rodríguez, Albino García-Sacristán, Medardo Hernández, Luis Rivera, Dolores Prieto
Reactive oxygen species (ROS) like hydrogen peroxide (H2O2) are involved in the in endothelium-derived hyperpolarization (EDH)-type relaxant responses of coronary and mesenteric arterioles. The role of ROS in kidney vascular function has mainly been investigated in the context of harmful ROS generation associated to kidney disease. The present study was sought to investigate whether H2O2 is involved in the endothelium–dependent relaxations of intrarenal arteries as well the possible endothelial sources of ROS generation involved in these responses. Under conditions of cyclooxygenase (COX) and nitric oxide (NO) synthase inhibition, acetylcholine (ACh) induced relaxations and stimulated H2O2 release that were reduced by catalase and by the glutathione peroxidase (GPx) mimetic ebselen in rat renal interlobar arteries, suggesting the involvement of H2O2 in the endothelium-dependent responses. ACh relaxations were also blunted by the CYP2C inhibitor sulfaphenazole and by the NADPH oxidase inhibitor apocynin. Acetylcholine stimulated both superoxide (O2.-) and H2O2 production that were reduced by sulfaphenazole and apocynin. Expression of the antioxidant enzyme CuZn-SOD and of the H2O2 reducing enzymes catalase and GPx-1 were found in both intrarenal arteries and renal cortex. On the other hand, exogenous H2O2 relaxed renal arteries by decreasing vascular smooth muscle (VSM) intracellular calcium concentration [Ca2+]i and markedly enhanced endothelial KCa currents in freshly isolated renal endothelial cells. CYP2C11 and CYP2C23 epoxygenases were highly expressed in interlobar renal arteries and renal cortex, respectively, and were co-localized with eNOS in renal endothelial cells. These results demonstrate that H2O2 is involved in the EDH-type relaxant responses of renal arteries and that CYP 2C epoxygenases are physiologically relevant endothelial sources of vasodilator H2O2 in the kidney.
Publication date: Available online 14 February 2017
Source:Archives of Physical Medicine and Rehabilitation
Author(s): Linda Resnik, Matt Borgia, Ben Silver, Jill Cancio
ObjectiveStudy purposes were to 1) identify outcome measures used in studies of persons with traumatic upper limb injury and/or amputation and 2) evaluate focus, content and psychometric properties of each measure.Data SourcesSearches of PubMed and CINAHL for terms including upper extremity, function, activities of daily living, outcome assessment, amputation and traumatic injuries.Study SelectionIncluded articles had a sample of ≥10 adults with limb trauma or amputation, and were in English. Measures containing a majority of items assessing impairment of body function or activity limitation were eligible.Data ExtractionTwo hundred sixty papers containing 55 measures were included. Data on internal consistency; test-retest, inter-rater, and intra-rater reliability; content, structural, construct, concurrent, and predictive validity; responsiveness; and floor/ceiling effects were extracted and confirmed by a second investigator.Data SynthesisResultsThe mostly highly rated performance measures included 2 amputation specific measures: Activities Measure for Upper Limb Amputees, University of New Brunswick Test of Prosthetic Skill and Spontaneity, and 2 non-amputation specific measures: Box and Block Test, and modified Jebsen-Taylor Hand Function test light and heavy cans tests. Most highly rated self-report measures were DASH, Patient Rated Wrist Evaluation, QuickDASH and Hand Assessment Tool (HAT), International Osteoporosis Foundation Quality of Life Questionnaire and Patient Rated Wrist Evaluation Functional Recovery subscale. None were amputation specific.ConclusionFew performance measures were recommended for patients with limb trauma and amputation. All top rated self-report measures were suitable for use in both groups. These results will inform choice of outcome measures for these patients.
http://ift.tt/2lIrHkp
Publication date: Available online 14 February 2017
Source:Critical Reviews in Oncology/Hematology
Author(s): Pieter Sonneveld, Edwin De Wit, Philippe Moreau
Although multiple myeloma (MM) remains incurable, the introduction of novel agents has improved clinical outcomes dramatically over the past 15 years. Response rates have risen from ∼30% with single agents to up to 90% with combination therapies. The immunomodulatory drugs (IMiDs) thalidomide and lenalidomide, and the proteasome inhibitor bortezomib, form the foundations for treatment of relapsed and/or refractory MM (RRMM). Newer agents, such as the IMiD pomalidomide, the histone deacetylase inhibitor panobinostat and the proteasome inhibitors carfilzomib and ixazomib, as well as the monoclonal antibodies daratumumab and elotuzumab, have further improved overall response rates in these patients. Importantly, increased response rates have been observed in heavily pretreated patients. The availability of highly effective and tolerable drugs may offer alternative treatment strategies to those who are unsuitable for treatment with thalidomide, lenalidomide or bortezomib. Improving tolerability of treatment regimens and lengthening progression‐free intervals has been shown to significantly improve health-related quality of life for patients living with RRMM.
http://ift.tt/2kHgLzi
Publication date: Available online 14 February 2017
Source:Pediatric Neurology
Author(s): Allison Johnson, Claudia Gambrah-Sampaney, Esha Khurana, James Baier, Esther Baranov, Baphaleng Monokwane, David R. Bearden
BackgroundChildren with cerebral palsy in low-resource settings are at high risk of malnutrition, which further increases their risk of poor health outcomes. However, there is little published data on specific risk factors for malnutrition among children with cerebral palsy in the developing world.MethodsWe performed a case-control study among children with cerebral palsy receiving care at a tertiary care hospital in Gaborone, Botswana. Children with cerebral palsy and malnutrition were identified according to World Health Organization growth curves and compared to subjects with cerebral palsy without malnutrition. Risk factors for malnutrition were identified using multivariable logistic regression models. These risk factors were then used to generate a Malnutrition Risk Score, and Receiver Operating Characteristic (ROC) curves were used to identify optimal cutoffs to identify subjects at high risk of malnutrition.ResultsWe identified 61 children with cerebral palsy, 26 of whom (43%) met criteria for malnutrition. Non-ambulatory status (OR 13.8, 95% CI 3.8-50.1, p<0.001) and a composite measure of socioeconomic status (OR 1.6, 95% CI 1.0-2.5, p=0.03) were the strongest risk factors for malnutrition. A Malnutrition Risk Score was constructed based on these risk factors, and Receiver Operating Characteristic (ROC) curve analysis demonstrated excellent performance characteristics of this score (AUC 0.92, 95% CI 0.89-0.94).ConclusionsMalnutrition is common among children with cerebral palsy in Botswana, and a simple risk score may help identify children with the highest risk. Further studies are needed to validate this screening tool and to determine optimal nutritional interventions in this population.
http://ift.tt/2lNV6p7
Publication date: Available online 14 February 2017
Source:Radiologic Clinics of North America
Author(s): Phoebe E. Freer, Nicole Winkler
Publication date: Available online 30 January 2017
Source:Radiologic Clinics of North America
Author(s): Melissa A. Durand, Regina J. Hooley
Publication date: 15 May 2017
Source:Journal of Environmental Management, Volume 193
Author(s): Zhenbang Cao, Jia Zhang, Jizhi Zhou, Xiuxiu Ruan, Dan Chen, Jianyong Liu, Qiang Liu, Guangren Qian
A zinc-dominant ferrite catalyst for efficient degradation of organic dye was prepared by the calcination of electroplating sludge (ES). Characterizations indicated that zinc ferrite (ZnFe2O4) coexisted with Fe2O3 structure was the predominant phase in the calcined electroplating sludge (CES). CES displayed a high decolorization ratio (88.3%) of methylene blue (MB) in the presence of H2O2 combined with UV irradiation. The high efficiency could be ascribed to the photocatalytic process induced by ZnFe2O4 and the photo-Fenton dye degradation by ferrous content, and a small amount of Al and Mg in the sludge might also contribute to the catalysis. Moreover, the degradation capability of dye by CES was supported by the synthetic ZnFe2O4 with different Zn to Fe molar ratio (n(Zn): n(Fe)), as 84.81%–86.83% of dye was removed with n(Zn): n(Fe) ranged from 1:0.5 to 1:3. All synthetic ferrite samples in the simulation achieved adjacent equilibrium decolorization ratio, the flexible proportioning of divalent metal ions (M2+) to trivalent metal ions (M3+) applied in the synthesis indicated that the catalyst has a high availability. Therefore, an efficacious catalyst for the degradation of dye can potentially be derived from heavy metal-containing ES, it's a novel approach for the reutilization of ES.
http://ift.tt/2kQrv0G
Publication date: June 2017
Source:Sensors and Actuators B: Chemical, Volume 245
Author(s): Zhenyin Hai, Mohammad Karbalaei Akbari, Chenyang Xue, Hongyan Xu, Stephen Depuydt, Serge Zhuiykov
Photodetector based on monolayer of tungsten trioxide (WO3) was fabricated by atomic layer deposition (ALD) and its structure and properties were analyzed by scanning electron microscopy (SEM), energy-dispersive spectroscopy (EDS), ellipsometry, atomic force microscopy (AFM), transmission electron microscopy (TEM) and spectrophotometry techniques. The as-developed photodetector exhibited high sensitivity, wide-range photoresponse, extremely fast response time of ∼2.5–2.7ms and superior long-term stability over more than 250 cycles. ALD-enabled Angstrom-precision development of monolayer WO3 with thickness of ∼0.74±0.07nm was done by utilizing (tBuN)2W(NMe2)2 as tungsten precursor and H2O as oxygen precursor, respectively, without affecting the underlying silicon substrate. The performance of monolayer WO3-based photodetector was much better than that of photodetectors based on other nanostructured WO3, monolayers and few layers of MoS2, MoSe2, GaSe and two-dimensional (2D) ZnO/ZnS nanocomposites. Its fast response speed also enables great application potential in high-frequency light-wave communications, various opto-chemical sensors, photo-switches and optoelectronic circuits.
Publication date: 15 May 2017
Source:Applied Surface Science, Volume 404
Author(s): Muhammad Hilmy Alfaruqi, Saiful Islam, Vinod Mathew, Jinju Song, Sungjin Kim, Duong Pham Tung, Jeonggeun Jo, Seokhun Kim, Joseph Paul Baboo, Zhiliang Xiu, Jaekook Kim
In this work, we demonstrate the first use of a V-doped MnO2 nanoparticle electrode for zinc-ion battery (ZIB) applications. The V-doped MnO2 was prepared via a simple redox reaction and the X-ray diffraction studies confirmed the formation of pure MnO2, accompanied by an anisotropic expansion of MnO2 lattice, suggesting the incorporation of V-ions into the MnO2 framework. V doping of MnO2 not only increased the specific surface area but also improved the electronic conductivity. When Zn-storage properties were tested, the V-doped MnO2 electrode registered a higher discharge capacity of 266mAhg−1 compared to 213mAhg−1 for the pure MnO2 electrode. On prolonged cycling, the doped electrode retained 31% higher capacity than that of the bare MnO2 electrode and thereby demonstrated superior cycling performance. This study may pave the way towards understanding the enhancement of the energy storage properties via doping in electrodes of aqueous ZIB applications and also furthers the efforts for the practical realization of a potential eco-friendly battery system.
Publication date: 15 May 2017
Source:Journal of Alloys and Compounds, Volume 704
Author(s): Jae-Yeol Hwang, Jun Yeon Ahn, Kyu Hyoung Lee, Sung Wng Kim
We report the enhancement of thermoelectric properties in the complex structured Cu-Bi-S pavonite compounds by optimizing the structural configuration through tuning the Bi-site occupancy, and substitutional doping at interstitial Cu sites by Zn. We verify that electronic transport properties depend on the structural deformation by the Bi site occupancy. Furthermore, we demonstrate that the modification of interstitial site ions enables selective control of thermal conductivity and intrinsically low thermal conductivity can be further suppressed by structural optimization without deteriorating electronic transport properties. We propose that understanding of crystal structure as a basic strategy permits the optimization of thermoelectric properties in the complex structures.
Publication date: 15 May 2017
Source:Journal of Hazardous Materials, Volume 330
Author(s): Anna Ricci, Luisa Massaccesi, Daniela Pezzolla, Giuseppe Corti, Alberto Agnelli, Giovanni Gigliotti
This study combined different approaches to characterize organic sediments produced by an anaerobic digestion plant feed with pig slurry, and accumulated for many years in a lagoon. The results of all analyses identified a certain homogeneity of the sediments. As a consequence of the pig diet, the sediment contained an high concentration of Zn (about 4gkg−1) and Cu (about 1.2gkg−1), which were mostly associated to the particles with a size ranging from 2 to 53μm. The sediment was made of large amount of organic matter, mostly cellulose and recalcitrant molecules, and 30–40% mineral fraction. XANES and XES spectroscopies indicated the presence of zinc phosphate (38%), zinc sulfide (32%), zinc carbonate (19%), and zinc oxide (11%). The presence in the sediment of forms characterized by a very scarce solubility, as also confirmed by the Zn and Cu chemical speciation, indicated a low bioavailability of these metals. However, although their low mobility, the high concentrations of Zn and Cu allowed to consider the sediment not suitable to use as a fertiliser due to the potential risk of metal interaction with the food chain.
http://ift.tt/2lNbfvZ
Publication date: March 2017
Source:Research in Developmental Disabilities, Volume 62
Author(s): Lara M. Genik, C. Meghan McMurtry, Lynn M. Breau
Some children with intellectual disabilities (ID): experience pain more frequently than children without ID, express their pain differently, and are incapable of providing self-reports. No research has examined disability and pain-related beliefs of respite workers (RW) and their relations to pain assessment and management decisions for children with ID.Objectives(1) compare disability and pain-related beliefs between RW and a sample with little experience in ID; (2) determine whether individuals' beliefs and personal characteristics are related to pain assessment and management decisions.ParticipantsFifty-six RW (aged: 18–67 years, Mage=33.37, 46 female) and 141 emerging adults (aged: 18–31 years, Mage=19.67, 137 female).Procedure/measuresIn an online survey, participants responded to six vignettes depicting pain in children with ID, and completed measures of pain and disability-related beliefs.Results/discussionCompared to those without experience, RW held more positive disability-related beliefs, t(192)=4.23, p<0.001. Participants' pain-related beliefs (e.g., sensitivity to pain) differed depending on severity of the child's ID and participant group. Participants' pain-related beliefs predicted care decisions. Results provide initial insight into RW pain-related beliefs about children with ID, and a basic understanding of the relations among pain beliefs, personal characteristics and pain-related decisions.
http://ift.tt/2lNeFOo
Publication date: Available online 14 February 2017
Source:Critical Reviews in Oncology/Hematology
Author(s): Pieter Sonneveld, Edwin De Wit, Philippe Moreau
Although multiple myeloma (MM) remains incurable, the introduction of novel agents has improved clinical outcomes dramatically over the past 15 years. Response rates have risen from ∼30% with single agents to up to 90% with combination therapies. The immunomodulatory drugs (IMiDs) thalidomide and lenalidomide, and the proteasome inhibitor bortezomib, form the foundations for treatment of relapsed and/or refractory MM (RRMM). Newer agents, such as the IMiD pomalidomide, the histone deacetylase inhibitor panobinostat and the proteasome inhibitors carfilzomib and ixazomib, as well as the monoclonal antibodies daratumumab and elotuzumab, have further improved overall response rates in these patients. Importantly, increased response rates have been observed in heavily pretreated patients. The availability of highly effective and tolerable drugs may offer alternative treatment strategies to those who are unsuitable for treatment with thalidomide, lenalidomide or bortezomib. Improving tolerability of treatment regimens and lengthening progression‐free intervals has been shown to significantly improve health-related quality of life for patients living with RRMM.
http://ift.tt/2kHgLzi
The benefits of asparaginase (ASNASE) in the treatment of ALL and NHL are indisputable and new ASNASE preparations are under clinical development to overcome limitations of the actual ASNASE therapy, especially immunogenicity. Apart from ALL and NHL further indications of ASNASE are preclinically and clinically evaluated.
We reviewed ASNASE literature and especially focused on the mechanism of action, on biomarker, which determine ASNASE sensitivity and resistance, and on ASNASE pharmacodynamics in vivo.
More than 40 years after the clinical introduction of ASNASE its mechanism of action is yet not fully understood. Studies on asparagine synthetase (ASNS) as biomarker for ASNASE resistance are contradictory and complicated by methodological obstacles. The role of glutamine hydrolysis for ASNASE efficacy is still debated, other mechanisms are possibly not yet identified. In addition, individual pharmacokinetic/-dynamic relationships cannot be properly addressed because of methodological limitations.
More sophisticated preclinical models and suitable methods for monitoring of ASNASE pharmacodynamics are urgently needed (1) to understand the mechanism of action, (2) to establish valid biomarkers for ASNASE sensitivity and resistance, (3) to evaluate the pharmacokinetics/-dynamics of ASNASEs in individual patients, and (4) to compare the bioequivalence of clinically established, as well as new ASNASE preparations.
Fragmentation of collagen fibrils, the major structure protein in skin, is a hallmark of dermal aging. Matrix metalloproteinases (MMPs) are largely responsible for fragmentation of collagen fibrils. However, the alteration of all known mammalian MMPs and the mechanism underlying altered expression of MMPs in chronologically aged human skin are less understood.
To quantify gene expression of all 23 known mammalian MMPs in sun-protected young and aged human skin in vivo, and investigate the potential mechanism underlying age-related alteration of multiple MMPs.
MMPs mRNA expression levels and MMPs activity in sun-protected young and aged human skin in vivo were determined by real-time RT-PCR and in situ zymography, respectively. The relative contributions to elevated MMPs in epidermis and dermis were quantified by laser capture microdissection (LCM) coupled real-time RT-PCR. Dermal fibroblast morphology and collagen fibrils fragmentation in human skin in vivo were assessed by second harmonic generation microscopy and atomic force microscopy, respectively. In vitro cell morphology was assessed by CellTracker® fluorescent dye and Phalloidin staining. Protein levels were determined by ProteinSimple capillary electrophoresis immunoassay.
Among all 23 known mammalian MMPs, multiple MMPs are elevated in aged human skin dermis. Consistent with this finding, increased MMPs activity and collagen fibrils fragmentation were observed in aged skin dermis. As dermal fibroblasts are the major MMPs producing cells in the dermis, reduction of dermal fibroblast size, which is observed in aged human skin, contributes to elevation of age-related multiple MMPs. Reduction of fibroblast size up-regulates c-Jun/c-Fos and activates AP-1, the major regulator of multiple MMPs.
Combined actions of the wide variety of MMPs that are constitutively elevated in aged dermis may be involved in progressive degradation of dermal collagen fibrils. Age-related elevations of multiple MMPs are likely resulted from the reduction of fibroblast size via activation of AP-1.
This article is protected by copyright. All rights reserved.
Human parvovirus B19 (B19V) has been associated with a number of dermatologic and systemic conditions, including myocarditis and autoimmune syndromes.
To determine the frequency of B19V deoxyribonucleic acid (DNA) detection in a large dermatopathology practice, and to characterize the histopathologic patterns involved.
We selected for polymerase chain reaction (PCR) detection of B19V a total of 1,815 skin biopsies pertaining to entities allegedly related to Parvovirus B19, as well as cases suspected clinically of representing paraviral exanthemas. Immunohistochemical detection of B19V viral protein 2 (VP2) was performed in 92 PCR-positive cases.
B19V DNA was found by PCR in 402 out of 1,825 biopsy specimens (22%). VP2 protein was identified by immunohistochemistry only in three instances of papular purpuric "gloves and socks" syndrome.
Since the virus has the capacity to persist in different tissues (including the skin) for long periods, it could represent merely an innocent bystander, so no pathogenetic significance can be inferred from the PCR positivity for B19V in the vast majority of dermatologic conditions studied.
This article is protected by copyright. All rights reserved.
Composting is an effective method in treating solid organic wastes, in which dissolved organic matter (DOM) plays an important role in transformation of organic matter and microbial activity. Therefore, an understanding of the properties and evolution of DOM during composting is crucial. In this study, DOM was studied using elemental analysis, spectroscopic analysis (UV-vis, FTIR, and pyrolysis-GC/MS), and colloidal analysis during a 120-day composting. Results showed that the content of N and O in DOM increased while C and H content declined progressively over the composting time. Aliphatic C–H stretching, aromatic C=C or C=O stretching of amide groups, and C–O stretch (carbohydrates) showed an obvious decrease, while COO– and C–N groups had a significant increase. The evolution of DOM indicated a gradual decrease of the lipid and polysaccharide fractions, whereas an increase of aromatic and nitrogenous compounds was observed. The DOM also showed a more stable status, and an accumulation of small molecular compounds occurred with composting proceeded. Taken together, these results shed a good insight into the properties and evolution of DOM during a composting process.
The black soldier fly Hermetia illucens is a good candidate for waste management. The harvested insects are rich in protein and have the potential to be used in animal feed. However, people are wary about heavy metals in waste. Therefore, it is necessary to understand how the uptake of heavy metals could affect H. illucens and where and to what extent metals are accumulated by the black soldier fly. Based on these considerations, developmental parameters were investigated in the different life stages of H. illucens fed an increasing concentration gradient of cadmium (Cd) and chromium (Cr); additionally, Cd and Cr distribution in the body parts of H. illucens at the different life stages was monitored. We found that Cd and Cr have no effects on larvae survival and eclosion rate, but they do have effects on larvae duration and pupation rate. Both Cd and Cr were transferred into larvae, prepupae, and pupae. While the concentrations of Cd in larvae and prepupae were much higher than that in their diets, the opposite case was observed with Cr. The concentrations of Cd and Cr in H. illucens decreased in later development stages. In individual larva and prepupa, Cd and Cr were mainly included in the body and not in the integument. In the pupa, the puparium contained higher Cd and Cr concentrations than the pupa body. The distribution of Cd and Cr in the different life stages and body parts may present a potential strategy for how H. illucens tolerate and remove heavy metal stress.
Hydrogen titanate (H2Ti3O7) nanotubes/nanosheets (HTN) are emerging class of adsorbent material which possess unique property of activating hydrogen peroxide (H2O2) to generate the reactive oxygen species (ROS), such as superoxide radical ions (O2.−) and hydroxyl radicals (·OH), effective in the decomposition of surface-adsorbed dye. However, HTN are non-magnetic which create hurdle in their effective separation from the treated aqueous solution. To overcome this issue, magnetic nanocomposites (HTNF) composed of HTN and maghemite (γ-Fe2O3) nanoparticles have been processed by subjecting the core–shell magnetic photocatalyst consisting of γ-Fe2O3/silica (SiO2)/titania (TiO2), having varying amounts of TiO2 in the shell to the hydrothermal conditions. HTNF-5 magnetic nanocomposite consisting of 31 wt% H2Ti3O7, typically having nanotube morphology with the highest specific surface area (133 m2 g−1) and pore-volume (0.22 cm3 g−1), exhibits the highest capacity (74 mg g−1) for the adsorption of cationic methylene blue (MB) dye from an aqueous solution involving the electrostatic attraction mechanism and pseudo-second-order kinetics. Very fast magnetic separation followed by regeneration of HTNF-5 magnetic nanocomposite has been demonstrated via non-radiation driven H2O2 activation. It has been ascertained for the first time that the underlying mechanism of dye decomposition involves the synergy effect between the constituents of HTNF magnetic nanocomposite.
Lessons Learned
Ideally, patients should have access to an oral formulation of paclitaxel, as well as an intravenous formulation, to allow development of regimens exploring alternate schedules and to avoid reactions to Cremophor EL (BASF Corp., Ludwigshafen, Germany, https://www.basf.com).
DHP107 is a novel oral paclitaxel formulation that is a tolerable and feasible regimen for patients with gastric cancer, with data suggesting efficacy similar to that of intravenous paclitaxel.
Background.We evaluated the maximum tolerated dose (MTD) of DHP107, a novel oral paclitaxel formulation, and the efficacy and safety of the agent in patients with advanced solid tumors.
Patients and Methods.Phase I study: cohorts of 3–6 patients with advanced solid tumors received escalating DHP107 doses. Phase IIa study: patients with measurable advanced gastric cancer received DHP107, 200 mg/m2 b.i.d., on days 1, 8, and 15 every 4 weeks. Pharmacokinetics, safety, and efficacy were analyzed.
Results.Phase I: 17 patients received a dose-escalating regimen of DHP107, 150–250 mg/m2 b.i.d. Dose-limiting toxicities were neutropenia and febrile neutropenia. The MTD (recommended dose) for phase IIa was 200 mg/m2 b.i.d. Phase IIa: 11 patients with measurable advanced gastric cancer in whom first-line therapy failed received DHP107 (MTD). Three confirmed partial responses were observed. Median progression-free survival of gastric cancer patients (n = 16) treated at the MTD was 2.97 (95% confidence interval, 1.67–5.40) months (Fig. 1). The most frequent grade 3/4 adverse events were neutropenia (35.3%) and leukopenia (17.6%) at the MTD (phase I and IIa combined; n = 17).
Conclusion.DHP107 showed good antitumor efficacy and was tolerable. The MTD (200 mg/m2 b.i.d.) is recommended for use in further studies comparing DHP107 with standard intravenous paclitaxel therapy. The Oncologist 2017;22:000–000
Publication date: Available online 14 February 2017
Source:European Journal of Vascular and Endovascular Surgery
Author(s): A. Sedrakyan, J.L. Cronenwett, M. Venermo, L. Kraiss, D. Marinac-Dabic, M. Björck
http://ift.tt/2ku28OV
Publication date: Available online 14 February 2017
Source:Journal of Electromyography and Kinesiology
Author(s): Mahboobeh Zabihhosseinian, Michael W.R. Holmes, Samuel Howarth, Brad Ferguson, Bernadette Murphy
BackgroundScapular orientation is highly dependent on axioscapular muscle function. This study examined the impact of neck muscle fatigue on scapular and humeral kinematics in participants with and without subclinical neck pain (SCNP) during humeral elevation.MethodsTen SCNP and 10 control participants performed three unconstrained trials of dominant arm humeral elevation in the scapular plane to approximately 120 degrees before and after neck extensor muscle fatigue. Three-dimensional scapular and humeral kinematics were measured during the humeral elevation trials.ResultsHumeral elevation plane angle showed a significant interaction between groups (SCNP vs controls) and trial (pre- vs post-fatigue) (p=.001). Controls began the unconstrained humeral elevation task after fatigue in a more abducted position, (p=.002). Significant baseline differences in scapular rotation existed between the two groups (Posterior/Anterior tilt, p=.04; Internal/External Rotation, p=.001).DiscussionSCNP contributed to altered scapular kinematics. Neck muscle fatigue influenced humeral kinematics in controls but not the SCNP group; suggesting that altered scapular motor control in the SCNP group resulted in an impaired adaption further to the neck muscle fatigue.
http://ift.tt/2l57OR9
Publication date: Available online 14 February 2017
Source:International Journal of Radiation Oncology*Biology*Physics
Author(s): Jenna Adleman, Caitlin Gillan, Amanda Caissie, Carol-Anne Davis, Brian Liszewski, Andrea McNiven, Meredith Giuliani
PurposeThe purpose of this study was to develop an entry-to-practice quality and safety competency profile for radiation oncology (RO) residency.Methods and MaterialsA comprehensive list of potential quality and safety competency items was generated from public and professional resources and interprofessional focus groups. Redundant or out-of-scope items were eliminated through investigator consensus. Remaining items were subjected to an international two-round modified Delphi process involving experts in RO, radiation therapy, and medical physics. During Round One, each item was scored independently on a 9-point Likert scale indicating appropriateness for inclusion in the competency profile. Items indistinctly ranked for inclusion or exclusion were reevaluated through web-conference discussion and re-ranked in Round Two.ResultsAn initial 1,211 items were compiled from 32 international sources and distilled to 105 unique potential quality and safety competency items. Fifteen of the 50 invited experts participated in Round One: 10 radiation oncologists, four radiation therapists, and one medical physicist from 13 centres in five countries. Round One rankings resulted in 80 items included, one item excluded, and 24 items indeterminate. Two areas emerged more prominently within the latter group: change management and human factors. Web-conference with five participants resulted in nine of these 24 items edited for content or clarity. In Round Two, 12 participants rescored all indeterminate items resulting in 10 items ranked for inclusion. The final 90 enabling competency items were organized into thematic groups consisting of 18 key competencies under headings adapted from Deming's System of Profound Knowledge.ConclusionsThis quality and safety competency profile may inform minimum training standards for RO residency programs.
Some plaque psoriasis patients experience secondary failure of tumour necrosis factor inhibitor therapy.
To evaluate efficacy, safety, and patient-reported outcomes (PROs) with etanercept in patients with secondary adalimumab failure.
This phase 4, open-label, single-arm, estimation study (NCT01543204) enrolled patients on adalimumab who had achieved static physician global assessment (sPGA) score 0/1 (clear/almost clear). Patients subsequently lost response, defined as sPGA ≥3 or loss of 50% improvement in Psoriasis Area and Severity Index (PASI 50). At baseline, patients had involved body surface area ≥10%, sPGA ≥3, and PASI ≥10. Anti-adalimumab antibodies (ADA) were measured at screening. Patients received etanercept 50mg twice weekly for 12 weeks followed by 50mg weekly. Primary endpoint was sPGA 0/1 at week 12 (intent-to-treat analysis; no hypothesis tested). Additional outcomes included rates of sPGA 0/1, PASI responses, safety, PROs of itch, pain, and flaking, Dermatology Life Quality Index (DLQI), treatment satisfaction, and Work Productivity and Activity Impairment (WPAI).
Sixty-four patients enrolled; 67% had ADA. Week 12 sPGA 0/1 rates (95% confidence interval) were 39.7% (27.6%-52.8%; primary endpoint); and 45.0% (29.3%–61.5%) for ADA-positive and 35.0% (15.4%–59.2%) for ADA-negative patients. Week 12 PASI 75 response rates (95% CI) were 47.5% (31.5%–63.9%) for ADA-positive and 50.0% (27.2%–72.8%) for ADA-negative patients. No new safety signals were observed. PROs of itch, pain, and flaking consistently improved at week 12 and were maintained through week 24.
Psoriasis patients with secondary failure of adalimumab achieved satisfactory response to etanercept regardless of ADA status.
This article is protected by copyright. All rights reserved.
Publication date: 13 February 2017
Source:Cancer Cell, Volume 31, Issue 2
Author(s): Romina E. Araya, Romina S. Goldszmid
Type I interferons have been shown to play a major role in anti-cancer immunity. In this issue of Cancer Cell, Katlinski et al. describe tumor-induced degradation of type I interferon receptor IFNAR1 chain as a new immune-evasion mechanism in colorectal cancers. Stabilizing IFNAR1 inhibits tumor growth and improves immunotherapy efficacy.
Publication date: 13 February 2017
Source:Cancer Cell, Volume 31, Issue 2
Author(s): D. Grahame Hardie
There has been controversy regarding the role of AMPK in cancer, some of which may be due to functional differences between isoforms. In this issue of Cancer Cell, Vila et al. report that UBE2O, a ubiquitin ligase overexpressed in some human cancers, specifically triggers the ubiquitination and degradation of AMPK-α2.